Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report

Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report

Abstract Background The nucleotide reverse transcriptase inhibitor Tenofovir Alafenamide (TAF) is a novel pro-drug of tenofovir (TFV) and possesses a superior renal safety profile compared with tenofovir disoproxil fumerate (TDF). Due to unique pharmacokinetic characteristics, treatment with TAF is...

Full description

Bibliographic Details
Main Authors: Jack E. Heron, Mark Bloch, Vinay Vanguru, John Saunders, David M. Gracey
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Nephrology
Subjects:
Fanconi syndrome
Tenofovir alafenamide
Antiretroviral therapy
Nephrotoxicity
Case report
Online Access:http://link.springer.com/article/10.1186/s12882-020-01981-9

Internet

http://link.springer.com/article/10.1186/s12882-020-01981-9

Similar Items